https://doi.org/10.4081/acbr.2024.491

Assessing the correlation between the benign prostatic hyperplasia Bother Impact Index and International Prostate Symptom Score after transurethral resection of the prostate

Vol. 5 No. 1 (2024)
Submitted: 12 March 2024
Accepted: 2 May 2024
Published: 28 May 2024
BPH, TURP, IPSS, BII
Abstract Views: 111
PDF: 70
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Okwudli Calistus Amu
okwudili.amu@unn.edu.ng
https://orcid.org/0000-0003-0672-5005
University of Nigeria Teaching Hospital Enugu, Nigeria.
Solomon Kenechukwu Anyimba
University of Nigeria Teaching Hospital Enugu, Nigeria.

Improvements in Lower Urinary Tract Symptoms (LUTS) and Quality of Life (QoL) are usually the key reasons men seek surgical options for their management. Transurethral Resection of the Prostate (TURP) is an effective surgical option for these patients, and it is increasingly being employed in the management of Benign Prostatic Hyperplasia (BPH) patients. The aim of this study was to evaluate the effect of TURP on the Bother Impact Index (BII) score and International Prostate Symptom Score (IPSS) and assess the correlation between these two parameters three months after TURP. This was a prospective study of 194 men who had TURP between February 2018 and October 2019. On clinical evaluation, all the patients included in the study had moderate to severe LUTS attributable to BPH. Preoperatively, detailed histories were taken of each patient, and the IPSS questionnaire was administered. The mean age of the participants was 66.28 years (Standard Deviation, SD=8.19). The modal age group was the sixth decade. The mean BII score of the patients was 5.73 (SD=0.45), and the mean IPPS of the patients was 25.85 (SD=5.07). The mean BII score 3 months post-TURP was 1.44 (SD±0.91), while the mean IPSS 3 months post-TURP was 2.75 (SD±1.33). There was a strong positive and statistically significant correlation between BII score and IPSS at 3 months post-TURP (r=+0.770, p<0.001).

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Hansen BJ, Flyger H, Brasso K, et al. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995;76:451-8. DOI: https://doi.org/10.1111/j.1464-410X.1995.tb07744.x
O’Leary MP. Validity of the ‘Bother Score’ in the evaluation and treatment of symptomatic Benign Prostatic Hyperplasia. Rev Urol 2005;7:1-10.
Barry MJ, Fowler FJ, O’Leary MP, et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 1992;148:1549-57. DOI: https://doi.org/10.1016/S0022-5347(17)36966-5
Chuang FP, Lee SS, Wu S, et al. Change in International Prostate Symptom Score after transurethral prostatectomy in Taiwanese men with benign prostate hyperplasia: use of these changes to predict the outcome. Arch Androl 2003;49:129-37. DOI: https://doi.org/10.1080/713828094
Batista-Miranda JE, Diez MD, Bertran PA, Villavicencio H. Quality-of-life assessment in patients with Benign Prostatic Hyperplasia; effects of various interventions. Pharmacoeconomics 2001;19:1079-90. DOI: https://doi.org/10.2165/00019053-200119110-00002
Thomas AW, Cannon A, Barlett E, et al. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow up of Transurethral Resection of Prostate for bladder outlet obstruction. J Urol 2005;174:1887-91. DOI: https://doi.org/10.1097/01.ju.0000176740.76061.24
Floratos DL, Kiemeney LA, Rossi C, et al. Long-term follow-up of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001;165:1533-8. DOI: https://doi.org/10.1016/S0022-5347(05)66343-4
Donovan JL, Peters TJ, Neal DE, et al. A randomized trial comparing Transurethral Resection of the Prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the CLasP study. J Urol 2000;164:65-70. DOI: https://doi.org/10.1016/S0022-5347(05)67450-2
Gujral S, Abrams P, Donovan JL, et al. A prospective randomized trial comparing Transurethral Resection of the Prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000;164:59-64. DOI: https://doi.org/10.1016/S0022-5347(05)67449-6
Doll HA, Black NA, Flood AB, McPherson K. Patient-perceived health status before and up to 12 months after Transurethral Resection of the Prostate for benign prostatic hypertrophy. Br J Urol 1993;71:297-305. DOI: https://doi.org/10.1111/j.1464-410X.1993.tb15946.x
Arai Y, Aoki Y, Okubo K, et al. Impact of interventional therapy for Benign Prostatic Hyperplasia on Quality of Life and sexual function: a prospective study. J Urol 2000;164:1206-11. DOI: https://doi.org/10.1016/S0022-5347(05)67142-X
Chalise PR, Agrawal CS. Changes in urinary symptoms and Quality of Life in men with Benign Prostatic Hyperplasia after Transurethral Resection of Prostate. Nepal Med Coll J 2007;9:255-8.
Milonas D, Verikaite J, Jievaltas M. The effect of the completeness of Transurethral Resection of the Prostate on symptoms, Quality of Life, and voiding function improvement. Cent European J Urol 2015;68:169-74. DOI: https://doi.org/10.5173/ceju.2015.507
Quek KF, Loh CS, Low WY, Razack AH. Quality of life assessment before and after Transurethral Resection of the Prostate in patients with Lower Urinary Tract Symptoms. World J Urol 2001;19:358-64. DOI: https://doi.org/10.1007/s003450100216
Fowler FJ. Patient reports of symptoms and Quality of Life following prostate surgery. Eur Urol 1991;20:44-9. DOI: https://doi.org/10.1159/000471746
O’Sullivan MJ, Murphy C, Deasy C, et al. Effects of Transurethral Resection of Prostate on the Quality of Life of patients with Benign Prostatic Hyperplasia. J Am Coll Surg 2004;198:394-403. DOI: https://doi.org/10.1016/j.jamcollsurg.2003.10.016
MacDonagh RP, Cliff AM, Speakman MJ, et al. The use of generic measures of health-related quality of life in the assessment of outcome From Transurethral Resection of the Prostate. Br J Urol 1997;79:401-8. DOI: https://doi.org/10.1046/j.1464-410X.1997.34017.x
Carter A, Sells H, Speakman M, et al. Quality of Life changes following KTP/Nd:YAG laser treatment of the prostate and TURP. Eur Urol 1999;36:92-8. DOI: https://doi.org/10.1159/000067977
Agrawal CS, Chalise PR, Bhandari BB. Correlation of prostate volume with International Prostate Symptom Score and Quality of Life in men with Benign Prostatic Hyperplasia. Nepal Med Coll 2008;10:104-7.
Udeh EI, Ozoemena OF, Ogwuche E. The relationship between prostate volume and International Prostate Symptom Score in Africans with Benign Prostatic Hyperplasia. Niger J Med 2012;21:290-5.
Ezz El Din K, Kiemeney LA, de Wildt MJ, et al. Correlation between uroflowmetry, prostate volume, postvoid residue, and Lower Urinary Tract Symptoms as measured by the International Prostate Symptom Score. Urology 1996;48:393-7. DOI: https://doi.org/10.1016/S0090-4295(96)00206-3

How to Cite

Amu, O. C., & Anyimba, S. K. (2024). Assessing the correlation between the benign prostatic hyperplasia Bother Impact Index and International Prostate Symptom Score after transurethral resection of the prostate. Annals of Clinical and Biomedical Research, 5(1). https://doi.org/10.4081/acbr.2024.491
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.